SEARCH

SEARCH BY CITATION

References

  • Altman, P.L., Grebe, R.M. & Katz, D.D. (1959) Handbook of Circulation. Saunders, Philadelphia.
  • Bartges, J.W. (2012) Chronic kidney disease in dogs and cats. Veterinary Clinics of North America: Small Animal Practice, 42, 669692.
  • Berendt, M., Gredal, H., Ersboll, A.K. & Alving, J. (2007) Premature death, risk factors, and life patterns in dogs with epilepsy. Journal of Veterinary Internal Medicine, 21, 754759.
  • Bialer, M., Johannessen, S.I., Levy, R.H., Perucca, E., Tomson, T. & White, H.S. (2013) Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). Epilepsy Research, 103, 230.
  • Blaisdell, J., Goldstein, J.A. & Bai, S.A. (1998) Isolation of a new canine cytochrome P450 CDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression. Drug Metabolism and Disposition, 26, 278283.
  • Boothe, D.M., Dewey, C. & Carpenter, D.M. (2012) Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs. Journal of the American Veterinary Medical Association, 240, 10731083.
  • Crespi, C.L. & Stresser, D.M. (2000) Fluorometric screening for metabolism-based drug–drug interactions. Journal of Pharmacological and Toxicological Methods, 44, 325331.
  • EMA (2012) CVMP Assessment Report for Pexion® (imepitoin) (EMEA/V/C/002543/0000), http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/veterinary/002543/WC500140842.pdf (date last accessed: 5 April 2013).
  • Frey, H.H. & Löscher, W. (1985) Pharmacokinetics of anti-epileptic drugs in the dog: a review. Journal of Veterinary Pharmacology and Therapeutics, 8, 219233.
  • Frey, H.H. & Schwartz-Porsche, D. (1985) Pharmacologic principles in the treatment of epilepsy in the dog and cat. Tierarztliche Praxis, 13, 541549.
  • Friedenberg, S.G., Butler, A.L., Wei, L., Moore, S.A. & Cooper, E.S. (2012) Seizures following head trauma in dogs: 259 cases (1999–2009). Journal of the American Veterinary Medical Association, 241, 14791483.
  • Gasparic, A. (2005) Investigations on biotransformation of AWD 131-138. Doctoral thesis, Faculty of Bioscience, Pharmacy and Psychology, University of Leipzig, Leipzig, Germany,
  • Gasparic, A., Schupke, H., Olbrich, M., Heinecke, K., Hempel, R., Hermann, R. & Kronbach, T. (2001) Morpholine ring oxidation of AWD 131-138, a novel anxiolytic and anticonvulsant, is catalysed by CYP1A1/2. Drug Metabolism Reviews, 33 (Suppl. 1), 89.
  • Greim, H. (1970) Increased synthesis and inhibited breakdown during the increase in microsomal cytochromes P-450 and b-5 by phenobarbital. Naunyn-Schmiedebergs Archiv fur Pharmakologie, 266, 260275.
  • Heinecke, K. & Thiel, W. (2001) Identity and physicochemical properties of 1-(4-chlorophenyl)-4-morpholino-imidazolin-2-one, AWD 131-138. Pharmazie, 56, 458461.
  • Johannessen, S.I. & Landmark, C.J. (2010) Antiepileptic drug interactions — principles and clinical implications. Current Neuropharmacology, 8, 254267.
  • Kearsley-Fleet, L., O'Neill, D.G., Volk, H.A., Church, D.B. & Brodbelt, D.C. (2013) Prevalence and risk factors for canine epilepsy of unknown origin in the UK. Veterinary Record, 172, 338.
  • Kwan, P., Schachter, S.C. & Brodie, M.J. (2011) Drug-resistant epilepsy. New England Journal of Medicine, 365, 919926.
  • Lidbury, J.A., Suchodolski, J.S., Ivanek, R. & Steiner, J.M. (2012) Assessment of the variation associated with repeated measurement of gastrointestinal transit times and assessment of the effect of oral ranitidine on gastrointestinal transit times using a wireless motility capsule system in dogs. Veterinary Medicine International, 2012, 938417
  • Löscher, W., Potschka, H., Rieck, S., Tipold, A. & Rundfeldt, C. (2004) Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures. Epilepsia, 45, 12281239.
  • Martignoni, M., Groothuis, G.M. & de Kanter, R. (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opinion on Drug Metabolism and Toxicology, 2, 875894.
  • Moore, S.A., Munana, K.R., Papich, M.G. & Nettifee-Osborne, J.A. (2011) The pharmacokinetics of levetiracetam in healthy dogs concurrently receiving phenobarbital. Journal of Veterinary Pharmacology and Therapeutics, 34, 3134.
  • Nychka, D., Haaland, P., O'Connell, M. & Ellner, S., (1998) FUNFITS, data analysis and statistical tools for estimating functions. In Lecture Notes in Statistics, Vol. 132. Case Studies in Environmental Statistics. Eds Nychka, D., Piegorsch, W.W. & Cox, L.H., pp. 159179. Springer-Verlag, New York.
  • Orishiki, M., Matsuo, Y., Nishioka, M. & Ichikawa, Y. (1994) In vivo administration of H2 blockers, cimetidine and ranitidine, reduced the contents of the cytochrome P450IID (CYP2D) subfamily and their activities in rat liver microsomes. International Journal of Biochemistry, 26, 751758.
  • Pacifici, G.M. & Viani, A. (1992) Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences. Clinical Pharmacokinetics, 23, 449468.
  • Paulson, S.K., Engel, L., Reitz, B., Bolten, S., Burton, E.G., Maziasz, T.J., Yan, B. & Schoenhard, G.L. (1999) Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metabolism and Disposition, 27, 11331142.
  • Podell, M., Fenner, W.R. & Powers, J.D. (1995) Seizure classification in dogs from a nonreferral-based population. Journal of the American Veterinary Medical Association, 206, 17211728.
  • Podell, M., Smeak, D. & Lord, L.K. (1998) Diazepam used to control cluster seizures in dogs. Journal of Veterinary Internal Medicine, 12, 120121.
  • Potschka, H., Fischer, A., von Rüden, E.L., Hülsmeyer, V. & Baumgärtner, W. (2013) Canine epilepsy as a translational model? Epilepsia, 54, 571579.
  • Rieck, S., Rundfeldt, C. & Tipold, A. (2006) Anticonvulsant activity and tolerance of ELB 138 in dogs with epilepsy: a clinical pilot study. The Veterinary Journal, 172, 8695.
  • Rostock, A., Tober, C., Dost, C., Rundfeldt, C., Egerland, U., Stark, B., Schupke, H., Kronbach, T., Lankau, H.-J., Unverferth, K. & Engel, J. (1998) AWD 131-138, ADD-233089. Anxiolytic, anticonvulsant. Drugs of the Future, 23, 253255.
  • Rundfeldt, C. & Löscher, W. (2014) The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy. CNS Drugs, 28, 2943.
  • Sakakibara, H., Ohura, T., Kido, T., Yamanaka, N., Tanimura, N., Shimoi, K. & Guruge, K.S. (2013) Organ-specific distribution of 7-chlorinated benz[a]anthracene and regulation of selected cytochrome P450 genes in rats. Journal of Toxicological Sciences, 38, 137143.
  • Schwartz, M., Munana, K.R. & Olby, N.J. (2011) Possible drug-induced hepatopathy in a dog receiving zonisamide monotherapy for treatment of cryptogenic epilepsy. Journal of Veterinary Medical Science, 73, 15051508.
  • Speciale, J., Dayrell-Hart, B. & Steinberg, S.A. (1991) Clinical evaluation of gamma-vinyl-gamma-aminobutyric acid for control of epilepsy in dogs. Journal of the American Veterinary Medical Association, 198, 9951000.
  • Trepanier, L.A., Van Schoick, A., Schwark, W.S. & Carrillo, J. (1998) Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992–1996). Journal of the American Veterinary Medical Association, 213, 14491453.
  • Walter, R., Siegmund, W. & Scheuch, E. (1996) Effects of interferon-γ and streptolysin O on hepatic procainamide N-acetyltransferase and various microsomal cytochrome P450-dependent monooxygenases in rats. Immunopharmacology and Immunotoxicology, 18, 571586.
  • Walter, R., Ullmann, C., Thummler, D. & Siegmund, W. (2003) Influence of propiverine on hepatic microsomal cytochrome p450 enzymes in male rats. Drug Metabolism and Disposition, 31, 714717.
  • Wright, H.M., Chen, A.V., Martinez, S.E. & Davies, N.M. (2012) Pharmacokinetics of oral rufinamide in dogs. Journal of Veterinary Pharmacology and Therapeutics, 35, 529533.
  • Ziółkowski, H., Jaroszewski, J.J., Ziółkowska, N. & Jasiecka, A. (2012) Characteristics of selected second-generation antiepileptic drugs used in dogs. Polish Journal of Veterinary Sciences, 15, 571582.